Services

Wet Formulation Development

MVIC supports you with experts in wet formulation and liquid inhalation development. From design and testing to regulatory support for nebulisers and sprays.

Expert Support in Liquid Inhalation and Wet Formulation Development

MVIC offers expert support in wet formulation development for inhalation, including nebulisers, nasal sprays, and soft mist inhalers. MVIC supports development of both solution and suspension formulation development. Our team of experts helps our clients to develop liquid-based inhalation products that are safe, effective, and compatible with selected delivery systems. Our services cover the full development cycle, from early formulation design and analytical method development to device compatibility testing and project management.

Our Services and Capabilities

MVIC offers a comprehensive suite of services to support every stage of liquid inhalation development. With deep expertise in wet formulation development, device integration, and regulatory strategy, we ensure that your project progresses efficiently and meets key development goals.

Strategic Start for Wet Formulation Projects

A successful inhalation project starts with a well-defined plan. We work with you to set clear clinical and regulatory objectives, ensuring a focused approach to wet formulation development. With deep experience in liquid inhalation development, we help select the most suitable device, define formulation parameters, and align your strategy with timelines, endpoints, and overall development goals.

Analytical Services for Liquid Inhalation Development

Accurate and reliable analysis is essential for successful liquid inhalation development. At MVIC, we offer tailored analytical method development for both material characterisation and aerosol performance testing. Our services include physicochemical profiling of APIs and excipients, development and validation of chemical assays, and de-engineering of reference products to support generic development.

liquid Formulation Development

We specialise in designing and optimising formulations for liquid inhalation development, with a focus on dose accuracy, solubility, and excipient compatibility. Our services include pH and osmolality adjustments, as well as reformulation and reverse engineering of complex products to support both innovation and generic development.

Device Testing for Liquid Inhalation

Consistent device performance is critical in wet formulation development. At MVIC, we perform in vitro testing to assess compatibility between formulation and device throughout the development process. We evaluate spray characteristics, aerosol behaviour, and support regulatory studies such as bioequivalence (BE) and PK — helping ensure your liquid inhalation development meets clinical and regulatory expectations.

End-to-End Project Management

MVIC offers dedicated and structured project management to support every phase of your liquid inhalation development. A dedicated MVIC Project Manager ensures smooth collaboration between all stakeholders while managing timelines, tracking milestones, and providing consistent reporting throughout the project lifecycle.

FAQs

Here you’ll find answers to some of the most common questions we receive. Still wondering about something? Feel free to get in touch – we’re happy to tell you more!

Yes, we offer reverse engineering and formulation optimisation support for both new and generic products.
We support a range of liquid delivery platforms including nebulisers, nasal sprays, and soft mist inhalers.
Liquid inhalation development focuses on formulating and testing inhalable solutions or suspensions to ensure they are safe, effective, and compatible with specific inhalation devices.
It involves the design and optimisation of liquid-based drug formulations intended for pulmonary or nasal delivery through devices like nebulisers or nasal sprays.